Multiple evidence exist that Nrf2, which is targeted by antioxidants, can not only prevent the development of cancer, but vice versa, potentiate the development of cancer and provide resistance to antitumor therapy, depending on the stage of disease and type of tumor [158,159]. This evidence concerns the gene NFE2L2 and neoplasm.